Eliminate Clozapine REMS, FDA Panels Say đź”— Access full article via Medscape NeurologyTwo FDA panels were almost unanimous in their opinion that the agency should eliminate restrictions that psychiatrists and patients say limit access to clozapine. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
